Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
JOIN THE CLUB
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
GO AD-FREE

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you downgrade to Basic or cancel with-in 10 days of first subscribing, we will refund your payment upon request. Immediately after downgrading or cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Devonian Health Group Inc. (V:GSD)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily
Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for GSD within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jun 05, 2019 12:45 ET
Devonian Announces the Filing of a New Patent Application Related to Use of Thylakoids as Delivery System for Cannabinoïds and Other Liposoluble Molecules
Devonian Health Group Inc. (“Devonian” or the “Corporation“) (TSXv: GSD), a clinical stage biopharmaceutical corporation, today announced that the Corporation has filed a patent application for the use of thylakoids as delivery system for cannabinoids and other liposoluble molecules for pharmaceutical and cosmetic applications.
Read full article
Jun 03, 2019 12:45 ET
Devonian Signs a Binding Letter of Intent with Histapharm Inc. to Extract and Manufacture Their Proprietary Botanical Pharmaceutical Product and to Enter into a Strategic Partnership for the Developme
Devonian Health Group Inc. (“Devonian” or the “Corporation“) (TSXv:GSD), a clinical stage biopharmaceutical corporation focused on developing a unique portfolio of botanical prescription drugs and cosmeceutical products, and Histapharm Inc. ("Histapharm"), a company pioneering the control of histamine level in various dysfunctions, announced today that they have signed a binding Letter of Intent ("LOI") to negotiate the terms establishing Devonian as the exclusive site for the extraction and manufacturin
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
1.37
8.84
16.65
Price to Book - most recent quarter
1.39
3.06
3.27
Price to Cash Flow per share - TTM
--
10.06
12.71
Price to Free Cash Flow per share - TTM
--
9.15
11.76
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jan 15, 2019777750
Dec 31, 2018270
Dec 31, 196900
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Devonian Health Group In is a late stage Canada-based botanical and pharmaceutical company. The Company adopts a therapeutic approach, which targets various worldwide unmet medical needs. The core business of the Company is the development of prescription botanical drugs, as well as derma-cosmeceutical products, which is divided into two main segments: Therapeutics and Derma-cosmeceuticals. The Therapeutics segment includes Thykamine, which is an active lead drug candidate confirmed in a number of pre-clinical and clinical studies targeting inflammation. The Derma-cosmeceuticals includes the first derma-cosmeceutical product of the Company, which is a women's anti-aging treatment consisting of day, night and eye creams.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $GSD.CA GSD.V

  • No tweets found

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $GSD.CA GSD.V

  • No tweets found